Company Filing History:
Years Active: 2005
Title: Michael Sundström - Innovator in Cytokine Receptor Technology
Introduction
Michael Sundström is a notable inventor based in Stockholm, Sweden. He has made significant contributions to the field of biotechnology, particularly in the area of cytokine receptor proteins. His innovative work has led to the development of a unique modified extracellular domain of a cytokine receptor.
Latest Patents
Sundström holds a patent for a modified cytokine receptor protein. This invention allows for the crystallization of the receptor without the need for a ligand molecule. The receptor is designed to be either a homo- or heterodimeric receptor, with specific segments contributing to a disordered structure being deleted. A preferred embodiment of this invention is the human growth hormone receptor (hGHR). He has 1 patent to his name.
Career Highlights
Michael Sundström is currently employed at Pharmacia AB, a company known for its advancements in pharmaceuticals and biotechnology. His work at Pharmacia has allowed him to explore and develop innovative solutions in the field of receptor technology.
Collaborations
Sundström has collaborated with notable professionals in his field, including Gunnar Norstedt. Their partnership has contributed to the advancement of research and development in cytokine receptor technology.
Conclusion
Michael Sundström's contributions to the field of biotechnology, particularly through his patented work on modified cytokine receptors, highlight his role as an innovator. His career at Pharmacia AB and collaborations with other experts further emphasize his impact on the industry.